Washington University School of Medicine/Siteman Cancer Center — St Louis, Missouri

Washington University School of Medicine/Siteman Cancer Center is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Washington University School of Medicine/Siteman Cancer Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumors, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL).

Sponsors: Novartis Pharmaceuticals, Umoja Biopharma.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University School of Medicine/Siteman Cancer Center?

Washington University School of Medicine/Siteman Cancer Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University School of Medicine/Siteman Cancer Center conducted?

Washington University School of Medicine/Siteman Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers Solid Tumors, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL).

Is Washington University School of Medicine/Siteman Cancer Center accredited by Crixeo Health?

Washington University School of Medicine/Siteman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington University School of Medicine/Siteman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.